Series 161 — Supervisory Analyst Regulations Exam Blueprint
Independent Series 161 exam blueprint for FINRA supervisory analyst regulations, research report approval, conflicts, disclosures, supervision, and final review.
How to Use This Exam Blueprint
Use this checklist as a practical study map for the FINRA Series 161 — Supervisory Analyst Qualification Examination (Part I: Regulations). It is designed for final review and readiness self-assessment, not as an official outline or a substitute for current FINRA materials.
For each topic area, ask:
- Can I identify the regulatory issue from a short fact pattern?
- Can I decide whether a research report, communication, disclosure, or supervisory action is acceptable?
- Can I distinguish “revise,” “approve,” “escalate,” “document,” and “prohibit”?
- Can I explain why the correct answer is better than a merely plausible answer?
Because Series 161 is the regulations part of the supervisory analyst qualification path, focus on applied regulatory judgment: research report approval, analyst conflicts, disclosure, communications rules, supervision, anti-fraud principles, and documentation.
Topic-Area Readiness Table
| Readiness area | What to review | You are ready when you can… |
|---|---|---|
| Supervisory analyst role | Approval responsibility, independence, escalation, report quality, supervisory judgment | Decide whether a research report may be approved, must be revised, or must be escalated before use |
| FINRA research rules | Equity and debt research rules, analyst conflicts, firm conflicts, distribution practices, public appearances | Identify conflicts and required disclosures from issuer, firm, analyst, and investment banking facts |
| Research report standards | Fair and balanced presentation, reasonable basis, price targets, ratings, valuation methods, risks, source support | Spot unsupported conclusions, promissory language, omitted risks, stale assumptions, and misleading emphasis |
| Communications with the public | Retail, institutional, correspondence, electronic communications, social media, seminars, public appearances | Classify the communication and determine the appropriate review, approval, disclosure, and recordkeeping concern |
| Analyst certifications | Regulation AC concepts, report certifications, public appearance certifications, compensation statements | Recognize when an analyst certification issue exists and what it is meant to address |
| Securities Act concepts | Offerings, prospectus-related issues, distribution activity, research around offerings, gun-jumping concerns | Recognize when research or communication may condition the market or conflict with offering restrictions |
| Exchange Act and anti-fraud | Manipulation, misstatements, omissions, insider trading, market conduct, broker-dealer responsibilities | Apply anti-fraud logic to research reports, selective disclosure, rumors, trading activity, and market-moving statements |
| Regulation FD and MNPI | Selective disclosure, issuer communications, analyst meetings, material nonpublic information, information barriers | Decide when information may not be used, must be escalated, or requires restricted/watch list handling |
| Regulation M and distributions | Distribution participants, market conditioning, trading/research sensitivity during distributions | Recognize distribution-related conflicts and improper market influence risks |
| Supervisory systems | Written supervisory procedures, report review workflow, exception handling, escalation, branch/electronic supervision | Match a failure to the missing control: approval, documentation, escalation, testing, or training |
| Books and records | Research files, approvals, communications, disclosures, certifications, complaints, corrections, withdrawal notices | Identify what should be retained or documented without confusing recordkeeping with approval itself |
| Ethics and professional conduct | Fair dealing, independence, conflicts, misuse of information, pressure from sales/trading/investment banking | Choose the answer that protects investors, preserves independence, and documents the supervisory decision |
Research Report Approval Checklist
Before approving a report, a Series 161 candidate should be able to walk through the report like a regulator or supervisory analyst.
Content Quality and Fair Presentation
Check whether the report:
- Has a clear subject issuer, security, sector, or product scope.
- Distinguishes facts from opinions, forecasts, and recommendations.
- States the basis for ratings, recommendations, or target prices.
- Uses assumptions that are supportable and not selectively chosen.
- Presents material risks, not only upside potential.
- Avoids exaggerated, promissory, sensational, or misleading language.
- Does not omit material facts that would change a reasonable investor’s interpretation.
- Uses current data or clearly explains reliance on older data.
- Attributes third-party data, issuer information, or market data appropriately.
- Avoids selective presentation of comparable companies, time periods, or valuation measures.
Recommendation and Rating Review
For ratings, target prices, and recommendations, ask:
| Question | Readiness cue |
|---|---|
| Is the rating defined? | You can explain what “buy,” “hold,” “sell,” “outperform,” or similar terms mean under the firm’s system |
| Is the rating consistent with the analysis? | You can spot a report where the text contradicts the rating or target |
| Is the price target supported? | You can identify whether valuation inputs, time horizon, and risks are disclosed |
| Are risks balanced with potential reward? | You can reject a one-sided report even if the conclusion may be popular |
| Is the change in rating explained? | You can identify when a downgrade, upgrade, suspension, or withdrawal needs clear support |
| Is the report stale or superseded? | You can decide when republication, correction, or withdrawal may be needed |
Approval, Revision, Escalation, or Rejection
| If you see… | Best supervisory response to recognize |
|---|---|
| Missing required conflict disclosure | Do not approve until corrected |
| Unsupported target price | Require analysis, assumptions, methodology, and risk disclosure |
| Possible material nonpublic information | Escalate immediately; do not publish or trade on it |
| Investment banking pressure to soften criticism | Preserve independence; escalate conflict or improper influence |
| Sales desk request for early access | Avoid selective dissemination; follow firm distribution procedures |
| Issuer request to alter recommendation | Limit issuer involvement to appropriate factual review; escalate improper influence |
| Misleading headline but balanced body text | Require revision; headlines are part of the communication |
| Third-party research with firm endorsement | Review adoption, entanglement, disclosures, and supervisory responsibility |
| Analyst personal conflict | Disclose where required and evaluate whether additional restrictions apply |
| Public rumor used as a key source | Verify, disclose uncertainty, or remove unsupported claim |
FINRA Research Rules and Conflict Areas
Series 161 readiness requires comfort with FINRA research-rule vocabulary and applied conflict analysis. Do not study these rules only as definitions; study them as scenario triggers.
| Conflict or control area | What to recognize in a question |
|---|---|
| Investment banking relationship | The firm’s banking role or expectation may create disclosure, independence, and timing concerns |
| Analyst compensation | Compensation tied to investment banking or specific transactions raises independence concerns |
| Analyst personal trading | Analyst, household, or related account trading may create conflicts and restriction issues |
| Firm ownership or financial interest | The firm’s financial stake in the subject company may require disclosure or control review |
| Market making or trading interest | Firm trading activity can create conflicts that must be disclosed or supervised |
| Issuer-paid research | Compensation or issuer involvement affects objectivity, disclosure, and supervisory scrutiny |
| Prepublication review | Review by non-research personnel, issuers, or investment banking can raise independence concerns |
| Selective dissemination | Giving favored clients, traders, or banking personnel early access is a red flag |
| Public appearances | Analyst statements outside the written report may still require disclosures and supervision |
| Debt research differences | Debt research has its own rule framework, including institutional-use distinctions and conflict controls |
| Third-party research | Determine whether the firm merely distributes it, adopts it, is entangled with it, or must supervise it more closely |
| Termination of coverage | Investors may need clear notice when coverage is suspended or discontinued |
Disclosure Readiness Checklist
A strong candidate can look at a fact pattern and identify which disclosures are likely relevant. Exact wording and current rule details should be confirmed in current study materials, but the issue recognition should be automatic.
Disclosure Categories to Review
- Firm investment banking relationship with the subject company.
- Firm expectation or solicitation of investment banking business.
- Firm or affiliate financial interest in the subject securities.
- Analyst or household financial interest.
- Analyst compensation conflicts.
- Market making or other trading-related conflict.
- Managed or co-managed offering relationship.
- Issuer-paid research or compensation for coverage.
- Rating system definitions.
- Ratings distribution and investment banking client distribution, where applicable.
- Valuation method and risks to target price.
- Price chart or historical ratings information, where applicable.
- Material conflicts known to the firm or analyst.
- Analyst certification statements.
- Public appearance disclosures.
Disclosure Quality Traps
| Weak disclosure | Why it is a problem |
|---|---|
| “The firm may have conflicts” | Too vague if a specific material conflict exists |
| Disclosure buried where investors are unlikely to see it | Disclosure must be meaningful, not merely technical |
| Disclosure contradicts the report | Inconsistency creates a misleading communication |
| Old disclosure carried forward without review | Conflicts change; stale disclosure can be false or incomplete |
| Boilerplate used for all issuers | May omit the actual conflict or imply conflicts that do not exist |
| Disclosure only in internal file | Investors may need disclosure in or with the communication |
| Disclosure made after selective distribution | Timing matters; later disclosure may not cure earlier misuse |
Regulation AC Readiness
Regulation AC is central to analyst accountability. Be ready to recognize what certifications are intended to address.
| Topic | Can you do this? |
|---|---|
| Research report certification | Identify that the analyst must certify the views expressed accurately reflect the analyst’s personal views |
| Compensation certification | Recognize the certification issue when compensation is connected, directly or indirectly, to recommendations or views |
| Public appearances | Identify when oral analyst statements may create certification or disclosure obligations |
| False certification risk | Recognize that a certification is not a formality if the report does not reflect the analyst’s true views |
| Supervisory review | Understand that certification does not replace supervisory review of the report |
Communications with the Public
Series 161 candidates should be able to classify communications and identify the compliance concern. The question may not say “research report” directly.
| Communication type or setting | What to watch for |
|---|---|
| Formal research report | Approval, disclosure, analyst certification, conflict review, fair presentation |
| Market commentary | Whether it becomes a recommendation or research-like communication |
| Sales material using research excerpts | Balanced presentation, context, disclosures, and approval |
| Email to clients | Whether it is correspondence, institutional communication, or retail communication; whether research rules are triggered |
| Social media post | Public communication risk, supervision, retention, links to reports, misleading brevity |
| Webinar or conference call | Public appearance disclosures, scripts, Q&A risks, selective disclosure |
| Internal-only draft | Information barriers, access controls, improper influence, recordkeeping |
| Third-party article forwarded by the firm | Adoption or entanglement, fair balance, disclosure, and supervision |
| Institutional-only research | Whether the recipient classification and institutional-use controls are valid |
| Reprinted report | Staleness, updates, continued accuracy, disclosures, and approval status |
Securities Act Readiness Areas
For Series 161, Securities Act concepts often matter because research can intersect with public offerings, underwriting, and market conditioning.
Be Ready to Recognize
- Registered offering versus exempt offering concepts.
- Prospectus and offering communication sensitivity.
- Research published near an offering.
- Gun-jumping or conditioning-the-market concerns.
- Underwriter, dealer, issuer, and affiliate roles.
- Liability for material misstatements or omissions.
- Due diligence concepts and reasonable investigation.
- Resale and restricted securities concepts at a high level.
- How offering participation can affect research publication, distribution, and disclosure.
Offering-Related Scenario Cues
| Scenario cue | Likely issue |
|---|---|
| “The firm is managing an upcoming offering” | Investment banking conflict, research timing, offering communication restrictions |
| “Analyst wants to initiate coverage just before the deal” | Independence, offering conditioning, required controls |
| “Research report highlights only issuer growth before distribution” | Possible promotional or misleading offering-related communication |
| “Banking asks to review the draft for tone” | Improper influence risk |
| “Issuer requests deletion of a risk factor” | Objectivity, issuer influence, misleading omission |
| “Sales wants to send the report to prospective offering investors” | Offering communication and fair disclosure concerns |
Exchange Act, Anti-Fraud, and Market Conduct Checklist
Be prepared to apply anti-fraud principles to research, trading, and market communications.
| Area | Readiness check |
|---|---|
| Material misstatement | Can you spot false or overstated claims in a report or public appearance? |
| Material omission | Can you identify when omitted risk, conflict, or adverse fact makes the report misleading? |
| Scienter or intent concepts | Can you recognize reckless or intentional misconduct in a fact pattern? |
| Manipulation | Can you identify conduct intended to move the market improperly? |
| Insider trading | Can you distinguish public information from material nonpublic information? |
| Tipping | Can you spot improper sharing of material nonpublic information? |
| Rumors | Can you determine when rumor-based research is unsupported or manipulative? |
| Trading ahead | Can you recognize misuse of unpublished research or impending rating changes? |
| Selective disclosure | Can you identify unfair early release of market-moving research? |
| Books and records | Can you link misconduct to missing, inaccurate, or incomplete records? |
Regulation FD and Material Nonpublic Information
A supervisory analyst must know when information cannot be used just because it is valuable.
MNPI Decision Prompts
Ask these questions in order:
- Is the information material?
- Is it nonpublic?
- Did it come from an issuer, insider, adviser, consultant, customer, or other source with a duty?
- Was it obtained through a channel that creates confidentiality concerns?
- Has it been broadly disseminated to the market?
- Does the firm need to restrict trading, restrict publication, escalate, or document the event?
- Would publication of the research reveal or exploit the nonpublic information?
Common MNPI Triggers
- Private meeting with company management.
- Unannounced earnings guidance.
- Pending merger, acquisition, restructuring, or financing.
- Unreleased clinical, regulatory, or product data.
- Nonpublic customer, supplier, or order-flow information.
- Information from an investment banking engagement.
- Information from a restricted or watch list issuer.
- Analyst learns of a pending rating change before publication.
- Selective access to draft issuer filings or confidential documents.
Regulation M and Distribution-Related Concerns
Regulation M readiness is about recognizing distribution-related market influence risk.
| If the fact pattern includes… | Think about… |
|---|---|
| Firm participating in a distribution | Whether research, trading, or communications could affect the market |
| Market activity during an offering | Stabilization, passive market making, restricted activity, or manipulation concerns |
| Research timed near a distribution | Whether publication appears to condition the market |
| Sales pressure around an offering | Whether communications are balanced and properly controlled |
| Purchases supporting the price | Manipulative conduct and distribution restrictions |
| Issuer or underwriter involvement | Independence, offering rules, and disclosure |
Supervisory Systems and Controls
The Series 161 candidate should be ready to identify the missing control. Many questions test the practical difference between a good control and a weak one.
| Control | What it should accomplish |
|---|---|
| Written supervisory procedures | Define who reviews research, how conflicts are checked, how approvals are documented, and when issues escalate |
| Supervisory analyst approval | Ensure reports meet content, disclosure, and rule requirements before distribution |
| Conflict review | Identify investment banking, firm, analyst, issuer, compensation, trading, and personal conflicts |
| Information barriers | Prevent misuse of investment banking, issuer, or MNPI sources |
| Restricted/watch lists | Control trading and research activity around sensitive issuers |
| Exception reports | Identify possible trading ahead, analyst personal trading issues, late approvals, or distribution anomalies |
| Access controls | Limit who can see drafts, unpublished reports, rating changes, and sensitive communications |
| Training | Ensure analysts and supervisors understand current research rules and firm procedures |
| Escalation process | Move legal, compliance, supervisory, or senior management issues to the right decision-maker |
| Recordkeeping | Preserve evidence of review, approval, disclosures, certifications, corrections, and distribution |
Books, Records, and Documentation Checklist
Be ready to match the document to the regulatory purpose.
| Artifact | Why it matters |
|---|---|
| Research report file | Shows the final approved version and supporting analysis |
| Draft history | May show improper influence, late changes, or unresolved supervisory concerns |
| Approval record | Demonstrates supervisory review before distribution |
| Disclosure checklist | Shows conflicts were considered and disclosed where required |
| Analyst certification | Supports Regulation AC compliance |
| Conflict inventory | Tracks firm, analyst, banking, trading, and issuer relationships |
| Restricted/watch list record | Supports MNPI and information-barrier controls |
| Distribution list | Helps evaluate selective dissemination and timing |
| Public appearance log | Supports disclosure and supervision of oral communications |
| Correction or retraction file | Shows how errors or misleading statements were addressed |
| Complaint or inquiry record | May trigger escalation, investigation, or reporting |
| Training record | Supports supervisory system evidence |
| Exception report | Helps identify patterns, not just isolated mistakes |
Can You Do This?
Use this as a direct readiness check. If you cannot confidently answer “yes,” that topic should go back into review.
Research Approval Skills
- Identify whether a communication is a research report, research-like communication, public appearance, sales material, or internal draft.
- Decide whether a report can be approved as written.
- Identify missing or inadequate disclosures.
- Spot unsupported ratings, price targets, forecasts, or valuation methods.
- Detect misleading headlines, charts, comparisons, or summaries.
- Recognize when a report must be escalated to legal or compliance.
- Distinguish a factual correction from a changed opinion or rating.
- Determine when coverage suspension or termination creates investor communication issues.
- Identify when third-party research creates firm responsibility.
- Recognize improper prepublication review or influence.
Conflict and Independence Skills
- Identify investment banking conflicts.
- Identify analyst compensation conflicts.
- Identify firm ownership, trading, or market-making conflicts.
- Identify analyst personal trading conflicts.
- Identify issuer-paid research concerns.
- Recognize pressure from sales, trading, or banking personnel.
- Recognize improper issuer influence.
- Distinguish disclosure as a remedy from prohibition or escalation.
- Decide when information barriers are relevant.
- Decide when a conflict should prevent publication, not merely be disclosed.
Anti-Fraud and MNPI Skills
- Distinguish public information from material nonpublic information.
- Recognize tipping and trading-ahead risk.
- Identify misleading omissions.
- Identify manipulative research or rumor-based conduct.
- Recognize Regulation FD concerns from issuer meetings and calls.
- Decide whether publication should stop pending escalation.
- Identify when a report could improperly condition the market during an offering.
- Apply fair dealing principles to report distribution.
Supervision and Records Skills
- Identify the correct supervisory control for a failure.
- Distinguish approval failure from recordkeeping failure.
- Recognize inadequate written supervisory procedures.
- Identify when exception reports should trigger investigation.
- Determine what evidence should exist in the research file.
- Recognize when late approval, oral approval, or undocumented approval is a problem.
- Identify when training, surveillance, or escalation is the best corrective action.
- Apply firm policy without confusing it with baseline regulatory requirements.
Scenario and Decision-Point Checks
| Scenario | What the exam may be testing | Ready response |
|---|---|---|
| Analyst receives private earnings guidance during an issuer call | MNPI, Regulation FD, information barriers | Do not publish or trade on the information; escalate and follow restricted/watch list controls |
| Investment banking asks to soften a negative report | Analyst independence and improper influence | Reject improper influence, document, and escalate |
| Report has a price target but no valuation method | Fair basis and disclosure | Require support, methodology, assumptions, time horizon, and risk discussion |
| Sales desk wants early access to a downgrade | Selective dissemination and trading ahead | Do not provide early access outside approved controls |
| Issuer reviews a draft and requests removal of criticism | Issuer influence and misleading omission | Limit factual review appropriately; do not let issuer control opinion |
| Third-party research is sent with firm branding | Adoption or entanglement | Determine firm responsibility, review, disclosures, and approval needs |
| Analyst owns securities of the covered issuer | Personal conflict | Evaluate disclosure, restrictions, and supervisory approval |
| Report issued near a public offering | Securities Act, Regulation M, conflicts | Check offering role, timing, communications restrictions, and disclosures |
| Public appearance repeats a buy recommendation | Public appearance disclosure and certification concepts | Ensure required disclosures and supervisory controls are addressed |
| Headline says “guaranteed upside” but report includes risks | Misleading communication | Revise; a misleading headline is not cured by buried cautionary text |
| Report relies on an internet rumor | Reasonable basis and anti-fraud | Verify, remove, qualify, or escalate; do not publish unsupported rumor as fact |
| Analyst changes rating after trader complaint | Independence and conflict | Review basis, document rationale, and escalate if pressure influenced the decision |
| Coverage is discontinued after a negative event | Termination of coverage and investor notice | Determine whether notice, explanation, or disclosure is needed |
| Institutional debt research is distributed broadly | Recipient classification and debt research controls | Confirm recipient eligibility, disclosures, and institutional-use procedures |
| Old report is reused in a client presentation | Staleness and republication | Review for current accuracy, updated disclosures, and approval status |
Common Weak Areas and Exam Traps
| Trap | How to avoid it |
|---|---|
| Treating disclosure as a cure for everything | Some facts require prohibition, revision, escalation, or restriction, not just disclosure |
| Ignoring the source of information | The same fact can be usable or unusable depending on whether it is public or nonpublic |
| Confusing “approved by a supervisor” with “compliant” | Approval must be informed, documented, and based on actual review |
| Assuming institutional clients need no protection | Institutional communications still require supervision, fair dealing, and appropriate controls |
| Missing public appearance issues | Analyst speeches, calls, panels, and media comments can trigger disclosure obligations |
| Overlooking issuer influence | Issuer factual review is different from issuer control over ratings or conclusions |
| Focusing only on the analyst | Firm conflicts, affiliate conflicts, banking relationships, and trading interests also matter |
| Ignoring distribution timing | Early release to selected clients or desks can be a serious issue |
| Memorizing rule names without triggers | Practice facts-to-rule recognition, not just vocabulary |
| Using outdated numerical details | Confirm current rule text for timing, thresholds, and retention specifics in current materials |
| Thinking Part I is securities analysis | Series 161 is regulations; valuation knowledge helps, but regulatory judgment is the focus |
| Choosing the least disruptive answer | Exams often favor investor protection, escalation, documentation, and independence over convenience |
Final-Week Review Checklist
Build a One-Page Rule Map
Create a compact sheet with four columns:
| Rule or concept | Trigger words | Required action | Common trap |
|---|---|---|---|
| Research conflicts | Banking, compensation, ownership, personal trading | Disclose, restrict, escalate, supervise | Disclosure too vague |
| Regulation AC | Analyst certification, public appearance | Certification and compensation statement concepts | Treating it as mere boilerplate |
| MNPI | Private call, nonpublic data, issuer tip | Stop, escalate, restrict, document | Publishing because the information is “reliable” |
| Securities Act | Offering, prospectus, underwriting | Review offering communication restrictions | Research used as promotion |
| Regulation M | Distribution, market support, trading | Identify manipulation/distribution controls | Ignoring firm role in distribution |
| Communications rules | Email, social post, seminar, excerpt | Classify, approve, disclose, retain | Assuming short messages are exempt |
| Supervision | WSPs, exception reports, approvals | Identify missing control | Confusing policy failure with isolated typo |
Drill With Short Fact Patterns
For each practice question or missed item, write the issue in one sentence:
- Conflict?
- Disclosure?
- MNPI?
- Offering restriction?
- Misleading statement?
- Improper influence?
- Selective dissemination?
- Missing approval?
- Missing record?
- Wrong communication classification?
Final Readiness Actions
- Re-read your notes on FINRA research rules for equity and debt research.
- Review analyst conflict and disclosure scenarios until issue spotting feels automatic.
- Practice classifying communications quickly.
- Review Regulation AC, Regulation FD, Regulation M, and anti-fraud concepts together.
- Review offering-related research restrictions and conflicts.
- Create a personal list of “revise vs escalate vs prohibit” examples.
- Review every missed practice question by regulatory concept, not by answer letter.
- Confirm current rule names, timing details, and firm-policy overlays in your primary materials.
- Spend extra time on scenarios where multiple issues appear in one fact pattern.
- On the day before the exam, focus on decision frameworks rather than learning new details.
Practical Next Step
Use this checklist to mark each topic as ready, uncertain, or needs review. Then complete mixed Series 161 practice questions that force you to approve, revise, escalate, or reject research-related communications. Review missed questions by rule family until you can explain the regulatory issue before looking at the answer choices.